LTR Pharma Limited (ASX: LTP)
Health Care · Pharmaceuticals · AU
AU$0.49
+3.19% today · -23.6% 1Y
LTR Pharma Limited (ASX: LTP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $61.69M.
Over the last twelve months the share price has lost 23.6%, trading between 0.35 and 0.75.
Tweenvest scores LTR Pharma Limited across four factors: quality 37/100, value 28/100. Its strongest factor is quality.
LTP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $61.69M
- Revenue (TTM)
- $500.82K
- P/E
- —
- EPS
- -0.08
- Dividend yield
- —
- Beta (5Y)
- 2.20
- 52-week high
- AU$0.75
- 52-week low
- AU$0.35
- Avg volume (3M)
- —
- Shares outstanding
- 182.27M
- Employees
- —
- Next earnings
- —
About LTR Pharma Limited
LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia.
- ISIN
- AU0000305294
- Founded
- 2020
- Listed since
- Dec 10, 2023
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| DK Life Science Co., Ltd.KOSDAQ: A303810 | $63.05M | ₩2,650.00 | -5.53% |
| Recce Pharmaceuticals LtdASX: RCE | $62.95M | AU$0.30 | -9.23% |
| InterCure Ltd.TASE: INCR | $62.72M | ₪16.22 | -3.97% |
| The Arab Drug CompanyCASE: ADCI | $62.33M | EGP272.01 | +0.00% |
| Theragen Etex Co.,Ltd.KOSDAQ: A066700 | $61.53M | ₩2,255.00 | -0.44% |
| CMG Pharmaceutical Co., Ltd.KOSDAQ: A058820 | $61.45M | ₩562.00 | +2.00% |
| Cinclus Pharma Holding AB (publ)OM: CINPHA | $61.43M | Skr12.76 | -3.33% |
| Daehan Nupharm Co.,Ltd.KOSDAQ: A054670 | $58.36M | ₩5,590.00 | +3.14% |
Figures last refreshed Oct 11, 2026.